NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Financial Report: Anthropic PBC's Revenue at Risk

Company Name: Anthropic PBC Industry: Artificial Intelligence Date: March 2024

Key Developments:

  • Anthropic PBC, a leading artificial intelligence startup, faces potential revenue losses of hundreds of millions to billions of dollars in 2026 due to a dispute with the US Defense Department over AI safety issues.
  • The company has filed a lawsuit against the Defense Department to block a supply-chain risk designation that could harm its business relationships with 100+ enterprise customers and impact a $50 million contract with a financial services company.
  • Anthropic's CEO, Dario Amodei, has stated that the government's actions are not "legally sound" and have left the company with "no choice but to challenge it in court."

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

Financial Implications:

  • Revenue at Risk: $100 million - $1 billion in 2026
  • Contract Impact: $50 million contract with a financial services company paused due to supply-chain risk designation
  • Industry Support: OpenAI, Google, and Microsoft have expressed support for Anthropic in the dispute over AI safety issues

Regulatory Developments:

  • US District Judge Rita F. Lin has moved up a hearing on Anthropic's request to block the supply-chain risk designation from April 3 to March 24
  • James Harlow, a lawyer for the Justice Department, has stated that the government will not offer any commitments on potential retaliatory actions against Anthropic.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Investor Takeaway

Investors should be cautious of potential losses for companies involved in AI technology due to government regulations.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.